Disclosed are novel compounds of formula (I)
wherein A
1
, A
2
, Ar, R
5
, R
6
, R
8
, M, Q, Y, Z, k, m and n are as defined in the specification. These compounds are useful in the treatment and/or prevention of conditions mediated by nuclear receptors, in particular the Peroxisome Proliferator-Activated Receptors (PPAR). Such conditions include diabetes and obesity.
揭示了一种新的化合物,其
化学式为(I),其中A1、A2、Ar、R5、R6、R8、M、Q、Y、Z、k、m和n的定义如规范中所述。这些化合物在治疗和/或预防由核受体介导的疾病方面具有用途,特别是
过氧化物酶体增殖激活受体(
PPAR)。这些疾病包括糖尿病和肥胖症。